Hormone health
Personalized menopause and hormone care. A clear, evidence-aware guide to candidacy, treatment, recovery, limitations and next steps.
Whole-person care
Private, individualized care begins by listening closely to your concerns, priorities and health goals.
The Short Answer
Women’s hormone care evaluates symptoms, life stage, health history and goals. Menopausal hormone therapy is the most effective treatment for vasomotor symptoms and genitourinary syndrome of menopause for appropriate candidates, but the formulation, route and duration require individualized risk assessment.
Candidacy
Many healthy symptomatic women younger than 60 or within 10 years of menopause onset may have a favorable benefit-risk profile, but candidacy is individual. Age, uterus status, migraine, clotting, cancer and cardiovascular history change the plan.
Systemic hormone therapy may be unsuitable with unexplained vaginal bleeding, certain estrogen-sensitive cancers, prior blood clots, stroke, heart attack, liver disease or other contraindications. Evaluation and alternative options are required.
At a Glance
These are practical planning ranges, not promises. Your consultation determines the exact plan.
Consultation about 30–60 minutes; testing is individualized
No anesthesia for consultation
None for consultation
Symptom response varies over weeks; follow-up is required
Individualized with periodic reevaluation
Ongoing monitoring rather than a fixed series
Your Visit
The provider reviews menstrual or menopause stage, symptoms, contraception needs, medical history and current medicines.
Testing is targeted; hormone levels are not always required to diagnose typical menopause. Preventive screening and bleeding history are checked.
If therapy is appropriate, route, dose, progesterone need, nonhormonal options and monitoring are discussed through shared decision-making.
Informed Choice
The main risk of skipping a complete assessment is receiving the wrong drug, dose or source. GLP-1 medicines have gastrointestinal and serious medical risks, and counterfeit or unapproved versions can add dosing and quality hazards.
Clinical Judgment
Obesity is a chronic medical condition, not a willpower problem. Experienced physician-supervised care addresses contraindications, comorbidities, lean-mass preservation, realistic rate of change and long-term maintenance.
Access & Cost
Initial and follow-up consultations may be available in-office or by telehealth for patients physically located in Texas, North Carolina or South Carolina, subject to law and clinical appropriateness. Examination, imaging or labs may be required.
Pricing: Consultation required. Cost depends on visit type, testing, medication, monitoring and insurance or pharmacy coverage.
Common Questions
“Bioidentical” does not automatically mean safer. FDA-approved estradiol and micronized progesterone options exist; compounded products have different oversight and evidence limitations.
No. The purpose of the visit is to determine the safest option, which may be a different medication or no medication.
Often, in eligible states, but abnormal bleeding, breast or pelvic concerns and some prescriptions require in-person evaluation or local testing.
Sources & Medical Review
